GT Biopharma
GTBP
GTBP
47 hedge funds and large institutions have $9.28M invested in GT Biopharma in 2022 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 11 increasing their positions, 20 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
45% less repeat investments, than reductions
Existing positions increased: 11 | Existing positions reduced: 20
67% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 12
Holders
47
Holding in Top 10
–
Calls
$78K
Puts
$2K
Top Buyers
| 1 | +$730K | |
| 2 | +$415K | |
| 3 | +$242K | |
| 4 |
AWS
Atria Wealth Solutions
New York
|
+$175K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$76.7K |
Top Sellers
| 1 | -$2.31M | |
| 2 | -$1.16M | |
| 3 | -$397K | |
| 4 |
Northern Trust
Chicago,
Illinois
|
-$374K |
| 5 |
Renaissance Technologies
New York
|
-$363K |